No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
BofA Securities Upgrades Erasca(ERAS.US) to Buy Rating, Announces Target Price $5
Erasca to Present at the 43rd Annual J.P. Morgan Healthcare Conference
One Erasca Insider Raised Stake By 14% In Previous Year
Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment
Clear Street Launches Healthcare & Biotechnology Equity Research
Stellantis, PG&E And Other Big Stocks Moving Lower In Monday's Pre-Market Session